compound 5 [PMID: 28038940]   Click here for help

GtoPdb Ligand ID: 9699

PDB Ligand
Compound class: Synthetic organic
Comment: Compound 5 [PMID: 28038940] is a covalent inhibitor of TAK1 kinase (MAP3K7) [2]. It was developed for its potential anti-proliferative activity in cells transformed by the KRAS oncogene.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 3
Rotatable bonds 8
Topological polar surface area 85.42
Molecular weight 463.19
XLogP 3.75
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C=CC(=O)Nc1ccccc1Nc1nc(ncc1Cl)Nc1ccc(cc1)N1CCN(CC1)C
Isomeric SMILES C=CC(=O)Nc1ccccc1Nc1nc(ncc1Cl)Nc1ccc(cc1)N1CCN(CC1)C
InChI InChI=1S/C24H26ClN7O/c1-3-22(33)28-20-6-4-5-7-21(20)29-23-19(25)16-26-24(30-23)27-17-8-10-18(11-9-17)32-14-12-31(2)13-15-32/h3-11,16H,1,12-15H2,2H3,(H,28,33)(H2,26,27,29,30)
InChI Key SCMLGVPMSXTUNC-UHFFFAOYSA-N
Bioactivity Comments
Compound 5 exhibited anti-proliferative activity against several AML or ALL cell lines [2]. In a live-cell kinase selectivity screen compound 5 (1 μM) showed potential polypharmacology, inhibiting TAK1 and AURKB > 90%, and FES, SLK, AURKA and MAP3K1 > 75%. Target engagement was shown using a biotinylated version of compound 5 in two KRAS mutant non-small cell lung cancer cell lines.
TAK1 is also implicated in inflammatory disorders [1]. To this end, compound 5 was found to normalise induced cytokine secretion from synovial fibroblasts derived from a rheumatoid arthritis patient [2]. However, the contribution of off-target effects to any biological effect must be considered.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
mitogen-activated protein kinase kinase kinase 7 Hs Inhibitor Inhibition 7.3 pIC50 - 2
pIC50 7.3 (IC50 5x10-8 M) [2]
Description: In a biochemical enzyme activity assay.